Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)
-
Published:2019-01
Issue:
Volume:106
Page:115-125
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Holch J.W.ORCID,
Ricard I.,
Stintzing S.ORCID,
Fischer von Weikersthal L.,
Decker T.,
Kiani A.,
Vehling-Kaiser U.,
Heintges T.,
Kahl C.,
Kullmann F.,
Scheithauer W.,
Moehler M.,
Jelas I.,
Modest D.P.,
Westphalen C.B.,
von Einem J.C.,
Michl M.ORCID,
Heinemann V.
Subject
Cancer Research,Oncology
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献